ATEC vs. ITGR, IART, ATRC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, and ABT
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Integer (ITGR), Integra LifeSciences (IART), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry.
Alphatec vs.
Alphatec (NASDAQ:ATEC) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.
Integer received 56 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 63.93% of users gave Integer an outperform vote while only 57.99% of users gave Alphatec an outperform vote.
66.3% of Alphatec shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 22.8% of Alphatec shares are owned by insiders. Comparatively, 2.0% of Integer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Integer has a net margin of 6.92% compared to Alphatec's net margin of -31.06%. Integer's return on equity of 11.65% beat Alphatec's return on equity.
Alphatec has a beta of 1.39, meaning that its share price is 39% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.24, meaning that its share price is 24% more volatile than the S&P 500.
In the previous week, Integer had 2 more articles in the media than Alphatec. MarketBeat recorded 11 mentions for Integer and 9 mentions for Alphatec. Alphatec's average media sentiment score of 1.29 beat Integer's score of 0.84 indicating that Alphatec is being referred to more favorably in the media.
Integer has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Alphatec presently has a consensus target price of $17.67, suggesting a potential upside of 71.19%. Integer has a consensus target price of $149.00, suggesting a potential upside of 25.19%. Given Alphatec's stronger consensus rating and higher possible upside, equities research analysts clearly believe Alphatec is more favorable than Integer.
Summary
Integer beats Alphatec on 11 of the 18 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
This page (NASDAQ:ATEC) was last updated on 3/25/2025 by MarketBeat.com Staff
